These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy]. Fan YJ, Zhou J, Li M. Yao Xue Xue Bao; 1983 Sep; 18(9):648-53. PubMed ID: 6677049 [No Abstract] [Full Text] [Related]
45. Dianhydrodulcitol treatment of lymphocytic choriomeningitis virus infection in suckling mice. Bános Z, Szeri I, Anderlik P. Acta Microbiol Acad Sci Hung; 1979 Sep; 26(1):29-34. PubMed ID: 484266 [Abstract] [Full Text] [Related]
52. Effect of a single high dose and repeated small doses of dianhydrogalactitol (DAG; NSC-132313) on rat intestinal mucosa. Kralovánszky J, Prajda N, Kerpel-Fronius S, Gál F, Szentirmay Z. Cancer Chemother Pharmacol; 1983 Sep; 11(3):167-71. PubMed ID: 6416695 [Abstract] [Full Text] [Related]
54. Effects of combination therapy with bleomycin (NSC-125066) and dibromodulcitol (NSC-104800) on squamous cell carcinoma in man. Onuma T, Holland JF, Sako K, Shedd DP. Cancer Chemother Rep; 1972 Oct; 56(5):625-33. PubMed ID: 4119907 [No Abstract] [Full Text] [Related]
55. Inhibitory and stimulatory effects of dianhydrogalactitol, an alkylating cytostatic agent on the humoral immune response. Gerö E, Gaál D. Oncology; 1986 Oct; 43(2):98-102. PubMed ID: 3951792 [Abstract] [Full Text] [Related]
60. Cytokinetics of a human neuroblastoma cell line following treatment with dianhydrogalactitol. Sordillo PP, Andreeff M, Helson L, Steinmetz J, Melamed MR. Cancer Invest; 1985 Oct; 3(4):321-5. PubMed ID: 4027754 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]